KZR

Kezar Life Sciences (KZR)

About Kezar Life Sciences (KZR)

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Details

Daily high
$0.86
Daily low
$0.81
Price at open
$0.82
52 Week High
$1.14
52 Week Low
$0.52
Market cap
60.2M
Dividend yield
0.00%
Volume
14
Avg. volume
1.4M
P/E ratio
-.61

Kezar Life Sciences News

Details

Daily high
$0.86
Daily low
$0.81
Price at open
$0.82
52 Week High
$1.14
52 Week Low
$0.52
Market cap
60.2M
Dividend yield
0.00%
Volume
14
Avg. volume
1.4M
P/E ratio
-.61